Seeking quick, inhaled fix for irregular heartbeats, Newark company drums up $30M

InCarda hopes to makes its drug-device available for atrial fibrillation patients to use at home, but it still must wait for two key late-stage clinical trials and more cash.
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news